Assiddiq, B., Tan, K., Toy, W., Chan, S., Chong, P., Lim, Y., & SINGAPORE, C. S. I. O. (2014). EGFR S1166 phosphorylation induced by a combination of EGF and gefitinib has a potentially negative impact on lung cancer cell growth.
Chicago Style CitationAssiddiq, B.F., K.Y Tan, W. Toy, S.P Chan, P.K Chong, Y.P Lim, and CANCER SCIENCE INSTITUTE OF SINGAPORE. EGFR S1166 Phosphorylation Induced By a Combination of EGF and Gefitinib Has a Potentially Negative Impact On Lung Cancer Cell Growth. 2014.
MLA引文Assiddiq, B.F., et al. EGFR S1166 Phosphorylation Induced By a Combination of EGF and Gefitinib Has a Potentially Negative Impact On Lung Cancer Cell Growth. 2014.
警告:這些引文格式不一定是100%准確.